Baxter International Inc. (BAX), headquartered in Deerfield, Illinois, develops and provides a portfolio of healthcare products. With a market cap of $11.7 billion, the company develops, manufactures, ...

BAX's second-quarter results may reflect pressured earnings and sales as manufacturing inefficiencies, inflation, and product ...

Baxter International has rebounded 21% YTD, outperforming after a prolonged decline, but I maintain a hold rating. BAX’s Q1 ...

Baxter International, a global healthcare products company with more than $15 billion in annual revenue, kicked off 2023 with the new year’s resolution of becoming streamlined and nimble. Five months ...

Quick ReadAbbVie's golden cross is widening with a 2.8% dividend yield, while Baxter's razor-thin cross sits atop a ...

Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming ...

Shares of Baxter International (NYSE: BAX) were tumbling 8.8% lower as of 11:24 a.m. ET on Thursday after falling as much as 11.8% earlier in the day. The decline came after the healthcare company ...

You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at info@rgrdlaw.com. CASE ALLEGATIONS: Baxter, through its subsidiaries, ...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming December 15, 2025 deadline to participate as a lead plaintiff in the securities fraud class action ...

Tariffs will likely cost Deerfield-based Baxter International $60 million to $70 million this year, the company’s chief financial officer said in an earnings call Thursday. Baxter expects to see most ...

Its final quarter of 2025 was mixed, with a notable whiff on earnings. On the plus side, it notched a convincing beat on revenue. Baxter's fourth quarter of 2025 saw total sales rise 8% year over year ...